BiotechTube
Data
Discover
News
Company
Search...
⌘K
Sign in
BiotechTube
Home
/
Cardiol Therapeutics
/
David Elsley
DE
David Elsley
President, CEO, Director
Cardiol Therapeutics
Therapeutic Areas
Cardiovascular
Cardiol Therapeutics Pipeline
Drug
Indication
Phase
CardiolRx™
Recurrent Pericarditis
Phase II
Leadership Team at Cardiol Therapeutics
DA
Dr. Andrew Hamer
Chief Medical Officer
DC
Dr. Colin Stott
Chief Operating Officer (R&D)
J(
John (Iain) Scott
Chief Financial Officer
DE
Dr. Eldon Smith
Chairman of the Board
View full Cardiol Therapeutics profile